Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments
- Authors
- Bose, Rajendran J. C.; Lee, Soo-Hong; Park, Hansoo
- Issue Date
- Aug-2016
- Publisher
- ELSEVIER SCI LTD
- Citation
- DRUG DISCOVERY TODAY, v.21, no.8, pp 1303 - 1312
- Pages
- 10
- Journal Title
- DRUG DISCOVERY TODAY
- Volume
- 21
- Number
- 8
- Start Page
- 1303
- End Page
- 1312
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6697
- DOI
- 10.1016/j.drudis.2016.06.005
- ISSN
- 1359-6446
1878-5832
- Abstract
- Biological barriers, such as phagocytosis and nonspecific distribution, are major factors limiting the clinical translation of nanomedicine. Biomimetic and bioengineering strategies have been used to overcome these challenges. In particular, natural cell membrane-based biofunctionalized nanoparticles (CMFNPs) have gained widespread attention owing to their cell surface mimetic characteristics and tailored nanomaterial features. These hybrid nanocarriers show strong potential for the delivery of myriad therapeutic agents. Herein, we highlight the most recent advances in CMFNP-based drug delivery systems and address the challenges and opportunities in the field.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of ICT Engineering > School of Integrative Engineering > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6697)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.